VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $4.90 million. The enterprise value is $1.43 million.
Important Dates
The last earnings date was Friday, February 6, 2026, before market open.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 2.61 million shares outstanding. The number of shares has increased by 84.51% in one year.
| Current Share Class | 2.61M |
| Shares Outstanding | 2.61M |
| Shares Change (YoY) | +84.51% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 4.14% |
| Float | 2.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.53 |
| Forward PS | 89.02 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.44 |
| Quick Ratio | 1.75 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -881.08 |
Financial Efficiency
Return on equity (ROE) is -51.07% and return on invested capital (ROIC) is -206.48%.
| Return on Equity (ROE) | -51.07% |
| Return on Assets (ROA) | -132.52% |
| Return on Invested Capital (ROIC) | -206.48% |
| Return on Capital Employed (ROCE) | -255.38% |
| Weighted Average Cost of Capital (WACC) | 10.05% |
| Revenue Per Employee | $10,143 |
| Profits Per Employee | -$87,643 |
| Employee Count | 14 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VivoSim Labs has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.19% in the last 52 weeks. The beta is 1.32, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -74.19% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 2.21 |
| Relative Strength Index (RSI) | 44.70 |
| Average Volume (20 Days) | 132,576 |
Short Selling Information
The latest short interest is 87,870, so 3.37% of the outstanding shares have been sold short.
| Short Interest | 87,870 |
| Short Previous Month | 774,911 |
| Short % of Shares Out | 3.37% |
| Short % of Float | 3.40% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $142,000 and -$1.23 million in losses. Loss per share was -$0.53.
| Revenue | 142,000 |
| Gross Profit | -3.78M |
| Operating Income | -11.45M |
| Pretax Income | -1.23M |
| Net Income | -1.23M |
| EBITDA | -11.22M |
| EBIT | -11.45M |
| Loss Per Share | -$0.53 |
Full Income StatementBalance Sheet
The company has $4.29 million in cash and $812,000 in debt, with a net cash position of $3.48 million or $1.33 per share.
| Cash & Cash Equivalents | 4.29M |
| Total Debt | 812,000 |
| Net Cash | 3.48M |
| Net Cash Per Share | $1.33 |
| Equity (Book Value) | 4.44M |
| Book Value Per Share | 1.70 |
| Working Capital | 3.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.62M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.62M |
| FCF Per Share | -$4.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,066.20% |
| Pretax Margin | -862.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.51% |
| Shareholder Yield | -84.51% |
| Earnings Yield | -25.03% |
| FCF Yield | -216.69% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
VivoSim Labs has an Altman Z-Score of -73.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -73.88 |
| Piotroski F-Score | 3 |
